Related Experiment Video

Updated: May 13, 2026

The use of SC1 (Pluripotin) to Support mESC Self-renewal in the Absence of LIF
05:58

The use of SC1 (Pluripotin) to Support mESC Self-renewal in the Absence of LIF

Published on: November 18, 2009

Activation of PDK-1 maintains mouse embryonic stem cell self-renewal in a PKB-dependent manner

L S Ling1, D Voskas, J R Woodgett

  • 11] Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada [2] Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.

Oncogene
|March 5, 2013
PubMed

Insights

The phosphatidylinositol 3' kinase (PI3K) pathway is crucial for maintaining embryonic stem cell self-renewal and pluripotency. Activating this pathway is sufficient to prevent differentiation, suggesting a role in cancer development.

Area of Science:

  • Molecular Biology
  • Stem Cell Biology
  • Cell Signaling

Background:

  • The phosphatidylinositol 3' kinase (PI3K) pathway regulates critical cellular functions like proliferation and survival.
  • Its role in embryonic stem (ES) cell fate determination, particularly self-renewal and pluripotency, is not fully understood.
  • Previous studies suggest PI3K inhibition impairs ES cell self-renewal and that glycogen synthase kinase-3 (GSK-3) is negatively regulated by PI3K.

Purpose of the Study:

  • To investigate the precise role of the PI3K signaling pathway in maintaining pluripotency and self-renewal of embryonic stem cells.
  • To determine if PI3K signaling is sufficient to maintain ES cell pluripotency.
  • To explore the potential link between PI3K's effect on ES cell differentiation and its oncogenic properties.

Main Methods:

  • Creation of stable, isogenic ES cell lines expressing activated alleles of 3-phosphoinositide-dependent protein kinase-1 (PDK1) and protein kinase B (PKB) using a modified Flp recombinase system.
  • In vitro characterization of these engineered cell lines to assess pluripotency maintenance.
  • Analysis of the phenotype's independence from canonical Wnt signal transduction.

Main Results:

  • Engineered ES cell lines exhibited a strong tendency to maintain pluripotency.
  • The observed maintenance of pluripotency was independent of canonical Wnt signaling.
  • PI3K signaling was found to be sufficient for maintaining stem cell self-renewal and survival.

Conclusions:

  • PI3K signaling plays a vital role in maintaining the self-renewal and pluripotency of embryonic stem cells.
  • The pathway's ability to suppress differentiation may contribute to its oncogenic potential when aberrantly activated in cancers.
  • These findings highlight PI3K as a key regulator of stem cell fate and a potential target in cancer therapy.

More Related Videos

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening07:18

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening

Published on: May 12, 2017

Oct4GiP Reporter Assay to Study Genes that Regulate Mouse Embryonic Stem Cell Maintenance and Self-renewal08:01

Oct4GiP Reporter Assay to Study Genes that Regulate Mouse Embryonic Stem Cell Maintenance and Self-renewal

Published on: May 30, 2012

Related Concept Videos

Maintenance of the ES Cell State01:14

Maintenance of the ES Cell State

The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...